FDA Approvals: Therapies for Lupus, MS, Cancer and a Genomic Alteration in Pigs
The Pharma Data
DECEMBER 17, 2020
MacroGenics, a biopharma company working to make cancer history with the development of innovative monoclonal antibody-based therapeutics, had its first product , MARGENZA , approved by the FDA on Wednesday. The FDA approval of Klisyri is a significant milestone for Athenex. Athenex, Inc.
Let's personalize your content